Cody Eric Bünger

Title: Cody Eric Bünger: Innovator in Biocompatible Scaffolds and Bioreactor Technology

Introduction

Cody Eric Bünger is a notable inventor based in Auning, Denmark. He has made significant contributions to the field of biocompatible materials and bioreactor technology. With a total of 2 patents, Bünger has developed innovative solutions that enhance cell growth and differentiation.

Latest Patents

Bünger’s latest patents include a "Three-dimensional nanostructured hybrid scaffold and manufacture thereof." This invention outlines a method for creating a biocompatible scaffold that supports cell activities. The scaffold features a supporting grid that forms an open network, allowing for mechanical support and nutrient diffusion. The design employs a hierarchically organized structure, utilizing both top/down and bottom/up manufacturing approaches to create a porous scaffold with specific nano-sized features. This innovative design promotes specific cell activities while ensuring mechanical compliance.

Another significant patent is the "Submerged perfusion bioreactor." This device is designed for biological applications such as cell culturing and enzymatic reactions. It features a body with first and second surfaces, an aperture, and rotating means that facilitate the flow of liquid medium. The design includes outlet channels that connect the aperture to a recessed portion, allowing for efficient liquid management within the device.

Career Highlights

Cody Eric Bünger has worked with prominent institutions such as Aarhus Universitet and Region Midtjylland. His experience in these organizations has contributed to his expertise in developing advanced biocompatible materials and bioreactor systems.

Collaborations

Bünger has collaborated with notable colleagues, including Jens Vinge Nygaard and Flemming Besenbacher. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

Cody Eric Bünger is a distinguished inventor whose work in biocompatible scaffolds and bioreactor technology has the potential to significantly impact the field of biological research. His innovative patents reflect a commitment to enhancing cell culture techniques and supporting scientific advancements.